Literature DB >> 9009103

Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.

A R Quesada1, M M Barbacid, E Mira, P Fernández-Resa, G Márquez, M Aracil.   

Abstract

To measure matrix metalloproteinase (MMP) activity in a large number of samples it is advisable to use easily automated methods. We have evaluated and compared the activity of stromelysin-1 (MMP-3), matrilysin (MMP-7), 72 kDa gelatinase A (MMP-2) and 92 kDa gelatinase B (MMP-9) by zymogram analysis and fluorescent substrate degradation assays. FITC-casein and the fluorogenic peptide Dnp-Pro-beta-cyclo-hexyl-Ala-Gly-Cys(Me)-His-Ala-Lys-(N-Me-Abz)-NH 2 were used as fluorescent substrates. FITC-casein was more efficiently degraded than the fluorogenic peptide by all MMPs tested except MMP-9. MMP-2 was not significantly able to degrade the fluorogenic peptide. Gelatin zymography was the most sensitive method to detect the activity of both gelatinases but quantitation problems compromise its use. The degradation of fluorogenic substrates by MMPs could be inhibited by the chelating agent EDTA and by the tissue inhibitor of metalloproteinases 2 (TIMP-2), an MMP-specific inhibitor. Fluorometric methods represent a good alternative for MMP activity measurement, especially when a large number of samples must be processed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009103     DOI: 10.1023/a:1018480222301

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  21 in total

Review 1.  Stromelysin/transin and tumor progression.

Authors:  L M Matrisian; G T Bowden
Journal:  Semin Cancer Biol       Date:  1990-04       Impact factor: 15.707

2.  Enhanced detection of casein zymography of matrix metalloproteinases.

Authors:  P Fernández-Resa; E Mira; A R Quesada
Journal:  Anal Biochem       Date:  1995-01-01       Impact factor: 3.365

Review 3.  Tumor cell interactions with the extracellular matrix during invasion and metastasis.

Authors:  W G Stetler-Stevenson; S Aznavoorian; L A Liotta
Journal:  Annu Rev Cell Biol       Date:  1993

4.  Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components.

Authors:  W A Galloway; G Murphy; J D Sandy; J Gavrilovic; T E Cawston; J J Reynolds
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

5.  Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line.

Authors:  K Miyazaki; Y Hattori; F Umenishi; H Yasumitsu; M Umeda
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 12.701

6.  Continuously recording fluorescent assays optimized for five human matrix metalloproteinases.

Authors:  S Netzel-Arnett; S K Mallya; H Nagase; H Birkedal-Hansen; H E Van Wart
Journal:  Anal Biochem       Date:  1991-05-15       Impact factor: 3.365

Review 7.  Type IV collagenases in invasive tumors.

Authors:  K Tryggvason; M Höyhtyä; C Pyke
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes.

Authors:  S S Twining
Journal:  Anal Biochem       Date:  1984-11-15       Impact factor: 3.365

9.  A new protease activity assay using fluorescence polarization.

Authors:  R Bolger; W Checovich
Journal:  Biotechniques       Date:  1994-09       Impact factor: 1.993

10.  Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells.

Authors:  B P Himelstein; R Canete-Soler; E J Bernhard; R J Muschel
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

View more
  11 in total

1.  The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.

Authors:  Jitesh Pratap; Amjad Javed; Lucia R Languino; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

2.  Biochemical properties of the matrix metalloproteinase NtMMP1 from Nicotiana tabacum cv. BY-2 suspension cells.

Authors:  Manoj K Mandal; Rainer Fischer; Stefan Schillberg; Andreas Schiermeyer
Journal:  Planta       Date:  2010-07-16       Impact factor: 4.116

3.  Matrix metalloproteinase 2 activity decreases in human periodontal ligament fibroblast cultures submitted to simulated orthodontic force.

Authors:  Rodolfo Assis Lisboa; Felipe Assis Lisboa; Guilherme de Castro Santos; Marcus Vinícius Melo Andrade; José Renan Cunha-Melo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-09-17       Impact factor: 2.416

4.  The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis.

Authors:  F X Weilbach; A Chan; K V Toyka; R Gold
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

5.  Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma.

Authors:  Y Oshita; T Koga; T Kamimura; K Matsuo; T Rikimaru; H Aizawa
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

6.  Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.

Authors:  Shanna Arnold; Emilia Mira; Sabeeha Muneer; Grzegorz Korpanty; Adam W Beck; Shane E Holloway; Santos Mañes; Rolf A Brekken
Journal:  Exp Biol Med (Maywood)       Date:  2008-04-29

7.  Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion.

Authors:  Jessica D Sims; Jessica McCready; Daniel G Jay
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

8.  Relaxin's induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants.

Authors:  Tabassum Naqvi; Trang T Duong; Gihan Hashem; Momotoshi Shiga; Qin Zhang; Sunil Kapila
Journal:  Arthritis Res Ther       Date:  2004-10-29       Impact factor: 5.156

9.  Matrix metalloproteinases in recurrent corneal melting associated with primary Sjörgen's syndrome.

Authors:  Kristyna Brejchova; Petra Liskova; Enkela Hrdlickova; Martin Filipec; Katerina Jirsova
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

10.  Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke.

Authors:  Kimberly E Hawkins; Kelly M DeMars; Changjun Yang; Gary A Rosenberg; Eduardo Candelario-Jalil
Journal:  Mol Brain       Date:  2013-03-23       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.